Elaine M. Hylek, MD
Professor
Boston University School of Medicine
Dept of Medicine
General Internal Medicine Section

MD, University of Pittsburgh School of Medicine
MPH, Harvard School of Public Health
MS, University of Pittsburgh



Expertise includes: Arterial Thrombosis; Venous Thrombosis; Atrial Fibrillation; Safety and Effectiveness of Antithrombotic Therapy.

Active Staff Privileges
Boston Medical Center
Department of Medicine



2011-2011 Other: Awarded Best Doctors in America 2007, 2009, 2011


Personnel agreement for research services of Elaine M. Hylek
01/01/2012 - 12/31/2013 (PI)
Department of Veterans Administration, Bedford

Personnel Agreement for Research Services of Elaine Hylek
01/01/2011 - 12/31/2011 (PI)
Department of Veterans Affairs

Phase II Study - Development and Implementation of Clinical Practice Guidelines in a Large Teaching Hospital for the Use of Fragmin as Bridging Therapy
07/01/2005 - 06/30/2007 (PI)
Pfizer, Inc.

Anticoagulation Consortium to Improve Outcomes Nationally (ACTION) Registry
03/01/2005 - 02/28/2007 (PI)
Bristol-Myers Squibb

Differences in Baseline Patient Characteristics and Their Contribution to the Disparate Efficacy Conclusions of SPORTIF III and SPORTIF V
06/07/2005 - 12/06/2006 (PI)
AstraZeneca


Effectiveness and Safety of Antithrombotic Strategies after Joint Replacement
02/16/2011 - 01/31/2017 (PI)
NIH-NHLBI
5R01 HL106029-04

Effect of Statins and Modifiable Factors on Stroke Outcome in Atrial Fibrillation
09/30/2010 - 07/31/2015 (PI)
NIH-NINDS
5R01 NS070307-03

IPA Agreement - Guneet Jasuja
06/01/2013 - 08/31/2014 (PI)
VA

BRIDGE Trial
11/01/2009 - 10/31/2010 (PI)
Duke Clinical Research Inst NIH-NHLBI
U01 HL087229


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d''Avila A, Natasja de Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. TEMPORARY REMOVAL: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2017 May 12.View Related Profiles. PMID: 28506916.
  2. Kapoor A, Ellis A, Shaffer N, Gurwitz J, Chandramohan A, Saulino J, Ishak A, Okubanjo T, Michota F, Hylek E, Trikalinos TA. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. J Thromb Haemost. 2017 Feb; 15(2):284-294. PMID: 28102615; DOI: 10.1111/jth.13566;.
  3. Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen LA, Kowey PR, Mahaffey KW, Hylek E, Peterson ED, Piccini JP, Fonarow GC. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation. JACC Heart Fail. 2017 Jan; 5(1):44-52. PMID: 28034376; DOI: 10.1016/j.jchf.2016.09.016;.
  4. Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, Thomas L, Wojdyla DM, Hanna M, Keltai M, Steg PG, De Caterina R, Wallentin L, van Gilst WH. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017 Mar; 185:140-149. PMID: 28267467; DOI: 10.1016/j.ahj.2016.12.008;.
  5. Raimondi P, Hylek EM, Aronis KN. Reversal agents for oral antiplatelet and anticoagulant treatment during bleeding events: current strategies. Curr Pharm Des. 2016 Dec 05. PMID: 27917717.
  6. Fanola CL, Mooney D, Cowan AJ, Ko D, Sisson EK, Henault LE, Tripodis Y, Hylek EM. Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants. Am Heart J. 2017 Feb; 184:150-155.View Related Profiles. PMID: 28224930; DOI: 10.1016/j.ahj.2016.08.017;.
  7. Ko D, Rahman F, Martins MA, Hylek EM, Ellinor PT, Schnabel RB, Benjamin EJ, Christophersen IE. Atrial fibrillation in women: treatment. Nat Rev Cardiol. 2017 Feb; 14(2):113-124.View Related Profiles. PMID: 27786235; DOI: 10.1038/nrcardio.2016.171;.
  8. Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Hylek EM, Verheugt F, Goto S, Alexander JH, Wallentin L, Granger CB. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation. Heart. 2017 Apr; 103(8):623-628. PMID: 27798052; DOI: 10.1136/heartjnl-2016-309901;.
  9. Ko D, Thigpen JL, Otis JA, Forster K, Henault L, Quinn E, Tripodis Y, Berger PB, Limdi N, Hylek EM. Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation. Int J Cardiol. 2017 Jan 15; 227:808-812.View Related Profiles. PMID: 28273786; DOI: 10.1016/j.ijcard.2016.10.055;.
  10. Pokorney SD, Shrader P, Thomas L, Fonarow GC, Kowey PR, Singer DE, Ansell J, Gersh BJ, Mahaffey KW, Hylek EM, Go AS, Piccini JP, Peterson ED. Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration''s Approach for Its Product Labeling. Circulation. 2016 Oct 11; 134(15):1122-1124. PMID: 27753615.
Showing 10 of 203 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 203 publications over 24 distinct years, with a maximum of 30 publications in 2014

YearPublications
19921
19941
19951
19961
19981
19991
20003
20013
20021
20036
20043
20052
20066
200710
200815
200911
20108
201118
20129
201321
201430
201523
201625
20173
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Antithrombotic Therapy
Atrial Fibrillation
Intracranial Hemorrhage
Stroke
Thrombosis

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:


801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Hylek's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department